Influence of gene-gene interactions on response to albuterol therapy

Pharmacogenomics

Volumn 12, Issue 1, 2011, Pages 1-3

  Moore, Paul E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADRB2; albuterol; asthma; desensitization; nitrosylation; pharmacogenetics

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR KINASE 2; SALBUTAMOL;

ASTHMA; BRONCHODILATATION; DESENSITIZATION; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG TARGETING; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NITROSYLATION; PHARMACOGENETICS; RECEPTOR DOWN REGULATION; REGULATORY SEQUENCE; REVIEW; SIGNAL TRANSDUCTION;

ALBUTEROL; ASTHMA; EPISTASIS, GENETIC; HUMANS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 78650444965     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.192     Document Type: Review

References (19)

1. Green SA, Turki J, Innis M, Liggett SB: Amino-terminal polymorphisms of the human b 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419 (1994).
2. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB: Infuence of b 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13, 25-33 (1995).
3. Hawkins GA, Weiss ST, Bleecker ER: Clinical consequences of ADRb2 polymorphisms. Pharmacogenomics 9, 349-358 (2008).
4. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP: An empirical evaluation of multifarious outcomes in pharmacogenetics: b-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenet. Genomics 16, 705-711 (2006).
5. Zhang G, Hayden CM, Khoo SK et al.: b2-adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking. Eur. Respir. J. 30, 48-55 (2007).
6. Drysdale CM, McGraw DW, Stack CB et al.: Complex promoter and coding region b 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA 97, 10483-10488 (2000).
7. Hawkins GA, Tantisira K, Meyers DA et al.: Sequence, haplotype, and association analysis of ADRb2 in a multiethnic asthma case-control study. Am. J. Respir. Crit. Care Med. 174, 1101-1109 (2006).
8. Moore PE, Williams SM, Gebretsadik T et al.: b(2)-adrenergic receptor promoter haplotype infuences spirometric response during an acute asthma exacerbation. Clin. Transl. Sci. 1(2), 155-161 (2008).
9. Panebra A, Wang WC, Malone MM et al.: Common ADRB2 haplotypes derived from 26 polymorphic sites direct b2-adrenergic receptor expression and regulation phenotypes. PLoS ONE 5(7), e11819 (2010).
10. Tantisira KG, Small KM, Litonjua AA, Weiss ST, Liggett SB: Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between b-agonist and corticosteroid pathways. Hum. Mol. Genet. 14(12), 1671-1677 (2005).
11. Moore PE, Ryckman KK, Williams SM, Patel N, Summar ML, Sheller JR: Genetic variants of GSNOR and ADRB2 infuence response to albuterol in African-American children with severe asthma. Pediatr. Pulmonol. 44(7), 649-654 (2009).
12. Wang WC, Mihlbachler KA, Bleecker ER, Weiss ST, Liggett SB: A polymorphism of G-protein coupled receptor kinase 5 alters agonist-promoted desensitization of b2-adrenergic receptors. Pharmacogenet. Genomics 18(8), 729-732 (2008).
13. Whalen EJ, Foster MW, Matsumoto A et al.: Regulation of b-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129, 511-522 (2007).
14. Ozawa K, Whalen EJ, Nelson CD et al.: S-nitrosylation of b-arrestin regulates b-adrenergic receptor traffcking. Mol. Cell. 31, 395-405 (2008).
15. Hahn LW, Ritchie MD, Moore JH: Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382 (2003).
16. Ritchie MD, Hahn LW, Moore JH: Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet. Epidemiol. 24, 150-157 (2003).
17. Choudhry S, Que LF, Yang Z et al.: GSNO reductase and b-2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenet. Genomics 20, 351-358 (2010).
18. Poon AH, Tantisira KG, Litonjua AA et al.: Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenet. Genomics 18, 373-382 (2008).
19. Corvol H, De Giacomo A, Eng C et al.: Genetic ancestry modifes pharmacogenetic gene-gene interaction for asthma. Pharmacogenet. Genomics 19, 489-496 (2009).